Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

The drug is available in several forms: immediate-release oral tablets and capsules extended-release oral tablets topical creams, gels, and lotions vaginal gels The different forms of ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% ...

The generic name of the gel is Metronidazole Vaginal Gel. "Metronidazole vaginal gel is a widely used antibacterial preparation, and its generic version can bring significant savings to the ...

Annual market sales for MetroGel-Vaginal® for the 12 months ending May 2019 were approximately $100 million as measured by IQVIA™. The product is manufactured by Perrigo and was developed ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

The product, a metronidazole vaginal gel to treat bacterial vaginosis, will compete against 3M Co's MetroGel-Vaginal product. 3M has said MetroGel-Vaginal accounted for about 2 percent of its 2005 ...